L

Lexington Biosciences Holdings Corp
OTC:LXGTF

Watchlist Manager
Lexington Biosciences Holdings Corp
OTC:LXGTF
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 38 USD

Profitability Summary

Lexington Biosciences Holdings Corp's profitability score is 57/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

57/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

57/100
Profitability
Score
57/100
Profitability
Score

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Lexington Biosciences Holdings Corp

Revenue
0 CAD
Operating Expenses
-170.9k CAD
Operating Income
-170.9k CAD
Other Expenses
0 CAD
Net Income
-170.9k CAD

Margins Comparison
Lexington Biosciences Holdings Corp Competitors

Country Company Market Cap Operating
Margin
Net
Margin
CA
Lexington Biosciences Holdings Corp
OTC:LXGTF
38 USD N/A N/A
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR N/A N/A
US
Suncast Solar Energy Inc
OTC:SUNC
517.6T USD
-47%
7%
US
GE Vernova LLC
NYSE:GEV
186.2B USD
4%
5%
US
China Industrial Group Inc
OTC:CIND
121B USD
10%
9%
NL
Nepi Rockcastle NV
JSE:NRP
86.5B Zac
84%
63%
CH
Galderma Group AG
SIX:GALD
38.5B CHF
16%
8%
US
Reddit Inc
NYSE:RDDT
42.4B USD
14%
18%
US
Coupang Inc
F:788
36B EUR
2%
1%
US
Symbotic Inc
NASDAQ:SYM
37.2B USD
-3%
-1%
US
CoreWeave Inc
NASDAQ:CRWV
34B USD
4%
-20%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Lexington Biosciences Holdings Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
Lexington Biosciences Holdings Corp
OTC:LXGTF
38 USD
18%
N/A
18%
23%
UK
Eight Capital Partners PLC
F:ECS
633.6T EUR N/A N/A N/A N/A
US
Suncast Solar Energy Inc
OTC:SUNC
517.6T USD
-6%
16%
49%
75%
US
GE Vernova LLC
NYSE:GEV
186.2B USD
19%
3%
8%
2%
US
China Industrial Group Inc
OTC:CIND
121B USD
39%
24%
37%
34%
NL
Nepi Rockcastle NV
JSE:NRP
86.5B Zac
12%
7%
9%
8%
CH
Galderma Group AG
SIX:GALD
38.5B CHF
5%
3%
7%
5%
US
Reddit Inc
NYSE:RDDT
42.4B USD
15%
14%
11%
57%
US
Coupang Inc
F:788
36B EUR
9%
2%
9%
7%
US
Symbotic Inc
NASDAQ:SYM
37.2B USD
-5%
-1%
-12%
-10%
US
CoreWeave Inc
NASDAQ:CRWV
34B USD
-32%
-4%
1%
1%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less